Trueblood Wealth Management LLC Invests $226,000 in Astera Labs, Inc. $ALAB

Trueblood Wealth Management LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 2,500 shares of the company’s stock, valued at approximately $226,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in shares of Astera Labs by 0.9% in the 1st quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company’s stock worth $554,780,000 after purchasing an additional 85,846 shares during the period. Alliancebernstein L.P. boosted its holdings in shares of Astera Labs by 114.2% in the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after purchasing an additional 4,478,741 shares during the period. Atreides Management LP boosted its holdings in shares of Astera Labs by 153.3% in the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock worth $277,601,000 after purchasing an additional 2,815,614 shares during the period. Fred Alger Management LLC boosted its holdings in Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock valued at $93,087,000 after acquiring an additional 179,638 shares during the period. Finally, FengHe Fund Management Pte. Ltd. purchased a new position in Astera Labs during the 2nd quarter valued at $106,772,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Down 3.9%

Shares of ALAB stock opened at $212.10 on Wednesday. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The stock has a market capitalization of $35.26 billion, a price-to-earnings ratio of 378.75, a P/E/G ratio of 5.50 and a beta of 1.43. The stock has a fifty day simple moving average of $193.63 and a two-hundred day simple moving average of $121.53.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business had revenue of $191.93 million during the quarter, compared to analysts’ expectations of $172.46 million. During the same period in the prior year, the business earned $0.13 EPS. The business’s revenue for the quarter was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft boosted their price objective on Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, September 2nd. Needham & Company LLC boosted their price objective on Astera Labs from $100.00 to $170.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price objective for the company. in a report on Tuesday, July 22nd. Jefferies Financial Group boosted their price objective on Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a report on Tuesday, July 22nd. Finally, Stifel Nicolaus set a $145.00 price objective on Astera Labs and gave the company a “buy” rating in a report on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $159.83.

Insiders Place Their Bets

In related news, General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the completion of the sale, the general counsel directly owned 151,573 shares in the company, valued at $29,126,267.68. This represents a 6.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Jitendra Mohan sold 91,441 shares of the company’s stock in a transaction on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $16,780,337.91. Following the sale, the chief executive officer owned 2,170,877 shares of the company’s stock, valued at $398,377,638.27. This trade represents a 4.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,320,054 shares of company stock worth $215,638,632. 12.50% of the stock is owned by company insiders.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.